Candel Therapeutics Inc (CADL)
SG&A Expense Growth
26.41%
Fiscal year · Period ending:
CADL SG&A Expense Growth
Latest reported26.41%period ending
Latest reported26.41%period ending
CADL FY SG&A Growth (YoY) (0.00% → 26.41%)
Latest values, visible window
High-resolution chart · PNG
CADL sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 26.4139% | |
| 1.2387% | |
| -1.2447% | |
| 31.7343% | |
| 106.0027% | |
| 102.7789% | |
| 0% |